The latest innovation from Pfizer Animal Health,
engineered for optimal fracture repair
TruScient® is the first and only recombinant human bone morphogenetic protein-2 (rhBMP-2) licensed for the treatment of diaphyseal fractures as an adjunct to standard surgical care using open fracture reduction in dogs. Partnering with the veterinary surgeon, it is proven to accelerate the time to radiographic fracture union.
On this site, you will find more information on what TruScient® is and how it works, clinical evidence for its efficacy, how to use it during open fracture repair, and a host of other useful educational materials.